Searched for
PIRAMAL PHARMA NEWS
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
Piramal Pharma shares in focus after US FDA issues six observations for Mumbai facilityPiramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, resulting in a F...
Buy IT stocks on dips; not big on pharma but like specific stocks: Chakri LokapriyaChakri Lokapriya highlights a selective approach toward pharma, favoring Cipla and Piramal for potential gains due to specific catalysts li...
Add Piramal Pharma, target price Rs 245: ICICI SecuritiesPiramal Pharma Ltd., incorporated in the year 2020, is a Small Cap company (having a market cap of Rs 30003.01 Crore) operating in Pharmace...
Buy Piramal Pharma, target price Rs 180: ICICI SecuritiesPiramal Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Other Operating Revenue for the year ending...
Piramal Pharma may double in a year; 4 metal stocks can give 20% return in 3 months : Sanjiv Bhasin"Jindal Steel has become an extremely attractive buy at this price, along with Tata Steel. Other than steel, Hindalco and Hindustan Copper....
Piramal Pharma stock rises over 3%. Here’s whyThe brokerage firm Jefferies assigned buy rating to Piramal Pharma with a target price of Rs 150, implying an upside potential of 20% from ...
Piramal Pharma Q2 Results: Piramal Pharma post net loss of Rs 37 crore in Q2FY23The complex hospital generic business that contributes one-third of revenues grew 12% YoY to Rs 562 crore. Piramal said it is witnessing st...
Piramal Pharma to inject funds into expansion, acquisitionsPiramal Pharma received a $360 million investment from US private equity company Carlyle Group in October 2020 in exchange for a 20% share....
Piramal Pharma shares hit 5% lower circuit after listingEarlier last week, the company obtained a go-ahead from the National Company Law Tribunal (NCLT) for the listing of its equity shares. Furt...
Piramal Capital raises Rs 1,400 crore to service debt, and for lendingPiramal Capital & Housing Finance has raised Rs 900 crore from two public sector banks — United Bank of India and Bank of India — at 8.9% f...
Piramal subsidiary sells stake in PISA to UK's Alliance Medical AcquisitioncoShares of Piramal Enterprises were trading 0.46 per cent higher at Rs 2,541 on BSE.
Piramal Enterprises, Navin Fluorine surge on fluorochemicals JVPiramal will hold 51 per cent of the equity share capital of the proposed joint venture company and the remaining 49 per cent will be held ...
- Sun Pharma promoters plan power sector foray; stock up
The promoters of India's fourth-largest pharmaceuticals company Sun Pharma are planning a Rs 5,000-crore foray into the power sector.
- Sun Pharma promoters plan power sector foray
The promoters of India's fourth-largest pharmaceuticals company Sun Pharma are planning a Rs 5,000-crore foray into the power sector, conti...
- GeNext promoters step into company boardrooms
Piramal Healthcare on Wednesday inducted Nandini Piramal, daughter of promoters Ajay and Swati Piramal, on to the company board, as part of...
- Piramal denies takeover bid by Glaxo
GlaxoSmithKline is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for around $1.5 billion.
- Glaxo in talks for Pirmal Healthcare
British pharma major GlaxoSmithKline Plc is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for arou...